imatinib mesylate has been researched along with Aphthae in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boralevi, F; Fricain, JC; Sibaud, V; Vigarios, E | 1 |
Akin Belli, A; Ayer, M; Barut, SG; Dervis, E | 1 |
1 review(s) available for imatinib mesylate and Aphthae
Article | Year |
---|---|
[Oral toxicity of targeted anticancer therapies].
Topics: Angiogenesis Inhibitors; Benzamides; ErbB Receptors; Glossitis, Benign Migratory; Humans; Hyperpigmentation; Imatinib Mesylate; Indoles; Maxillary Diseases; Molecular Targeted Therapy; Mouth Mucosa; Osteonecrosis; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyrimidines; Pyrroles; Radiation Injuries; Radiotherapy; Stomatitis; Stomatitis, Aphthous; Sunitinib; TOR Serine-Threonine Kinases | 2014 |
1 other study(ies) available for imatinib mesylate and Aphthae
Article | Year |
---|---|
Cutaneous adverse reactions of imatinib therapy in patients with chronic myeloid leukemia: A six-year follow up.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Agents; Cheilitis; Cross-Sectional Studies; Drug Eruptions; Edema; Exanthema; Female; Follow-Up Studies; Humans; Hyperhidrosis; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Pigmentation Disorders; Stomatitis, Aphthous; Time Factors; Young Adult | 2016 |